Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOTEPREDNOL ETABONATE vs LUCENTIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOTEPREDNOL ETABONATE vs LUCENTIS: Safety Overview

Metric	LOTEPREDNOL ETABONATE	LUCENTIS
Total FAERS Reports	1,630	686
Deaths Reported	4	184
Death Rate	0.2%	26.8%
Hospitalizations	45	180
Average Patient Age	65.7 yrs	71.6 yrs
% Female Patients	78.3%	N/A
FDA Approval Date	Apr 12, 2023	N/A
Manufacturer	Bausch & Lomb Incorporated	N/A
Route	OPHTHALMIC	N/A
Marketing Status	Prescription	N/A